 double-blind placebo-control trial intraven immunoglobulin therapi patient chronic fatigu syndrom purpos chronic fatigu syndrom cf profound fatigu neuropsychiatr dysfunct frequent abnorm cell-medi immun effect therapi patient method forty-nin patient abnorm cell-medi immun random double-blind placebo-control trial effect high-dos immunoglobulin patient intraven infus placebo solut immunoglobulin dose g/kg/month assess sever symptom associ disabl treatment detail interview physician psychiatrist unawar treatment statu addit chang physic symptom function capac visual analogu scale chang psycholog morbid patient-r indic depress cell-medi immun t-cell subset analysi delayed-typ hypersensit skin test lymphocyt transform phytohemagglutinin result interview physician month final infus immunoglobulin recipi placebo recipi substanti reduct symptom recommenc work leisur social activ patient improv physic psycholog immunolog measur conclus immunomodulatori treatment immunoglobulin effect signific number patient cf find concept immunolog disturb import pathogenesi disord